OHLCX Market Research
Delayed

LLY

Eli Lilly and Company is a global pharmaceutical company that develops and markets medications in various therapeutic areas, including diabetes, oncology, and immunology.

−3.06 (−0.23%) Nov 20, 2026 20:00 ET Delayed
Open
1,344.00
High
1,372.05
Low
1,341.76
Prev close
1,351.12
Volume
4M
Avg vol 10
3M

Today · Market closed · opens Mon 9:30 AM

Price

LLY chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 1,348.06

Strong sellNeutralStrong buy
Neutral
score 0.00 · 18 signalling
5Buy
8Neutral
5Sell

No clear lean. 5 buy, 8 neutral and 5 sell across 18 signals. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is strong (ADX 33).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 33.31 · Signal 46.66 · Hist −13.35
Sell
ADX 14
Strong trend, +DI slightly ahead
ADX 32.82 · +DI 27.44 · −DI 23.64
Buy
Parabolic SAR 0.02, 0.2
Above price, 124.52 over the close
1,472.57
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 1,408.36 · Base 1,357.17 · A 1,199.07 · B 1,200.91
Buy

Momentum

RSI 14
Mid-range, no extreme
49.66
Neutral
Stoch 14, 3
Oversold, %K still below %D
%K 10.45 · %D 19.31
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K still below %D
%K 0.00 · %D 6.28
Neutral
Williams %R 14
Oversold zone, falling
−89.55
Neutral
CCI 14
Below −100, turning up
−134.58
Buy
MFI 14
Below midpoint, not oversold
48.40
Neutral
ROC 12
Price down 4.93% over 12 bars
−4.93%
Sell
AO 5, 35
Above zero, falling
82.41
Neutral
TRIX 18
Above zero
0.525
Buy
KST 10/15/20/30, 3
Below its signal line
KST 141.52 · Signal 149.53
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.33
Up 1,486.54 · Mid 1,383.96 · Low 1,281.37
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 1,431.85 · Mid 1,368.69 · Low 1,305.53
Neutral

Volume

VWAP 345-bar
Close 36.5% above VWAP
987.64
Buy
Force Index 1
Negative, sellers in control
−11.0M
Sell
ATR
42.43
3.15% of close
A/D Line
−8.4M
cumulative
OBV
79.7M
cumulative
Volume Profile
988.70 – 1,049.51
POC · bull 132.1M · bear 123.0M · 52 / 48
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

3.09%

Change in value over the past month.

3 month return

8.03%

Change in value over the last three months.

Max drawdown

23.18%

Largest fall from a peak to the low that followed.

Standard deviation

36.53%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.86

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.35

Annualised return against the maximum drawdown.

About

LLY summary

Loading summary…

Questions

LLY, answered

Where can I find Eli Lilly’s financial statements?

You can access Eli Lilly’s financial statements on the investor relations section of their official website.

How can I stay updated on Eli Lilly news?

Stay updated through financial news websites, press releases, and Eli Lilly’s official communications.

Does Eli Lilly pay dividends?

Yes, Eli Lilly has a history of paying dividends to its shareholders, with quarterly payments.

What do analysts say about Eli Lilly stock?

Analyst ratings and opinions can be found on investment research platforms and major financial news sites.

How can I invest in Eli Lilly stock?

You can invest in LLY stock through a brokerage account or by consulting with a financial advisor.

What are the key products offered by Eli Lilly?

Key products include insulin therapies, cancer treatments, and medications for depression and autoimmune diseases.

What factors affect Eli Lilly’s stock price?

Factors include clinical trial results, regulatory approvals, and overall market conditions in the pharmaceutical industry.

How does Eli Lilly contribute to global health?

Eli Lilly engages in global health initiatives, providing access to medicines and supporting healthcare improvements worldwide.

Is Eli Lilly publicly traded?

Yes, Eli Lilly is publicly traded on the New York Stock Exchange under the ticker symbol LLY.

What is the outlook for Eli Lilly’s stock?

The outlook depends on pipeline successes, regulatory changes, and overall market conditions impacting the pharmaceutical industry.

News

LLY in the news

Supercharge Your LLY Trading Now

Empower your trading with ohlcx.com. Our comprehensive platform delivers precise analysis and strategic insights for LLY, designed to improve your trading outcomes. Transform your trading strategy now and unlock new opportunities with our advanced system!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.